The Cytotoxicity of RNase-Derived Peptides

Vera Ulyanova1, Elena Dudkina1, Alsu Nadyrova1

  • 1Department of Microbiology, Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Biomolecules
|December 30, 2020
PubMed

Insights

Bacterial binase peptides targeting cancer cells were identified. Specific regions (21-50 and 74-94) show potent cytotoxicity against HeLa, BT-20, and MCF-7 cells, with potential for tumor-targeting therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Bacterial binase demonstrates cytotoxic effects on oncogene-expressing tumor cells.
  • Understanding the specific cytotoxic mechanisms and structural components of binase is crucial for therapeutic development.

Purpose of the Study:

  • To pinpoint the structural regions of binase responsible for its cytotoxic activity.
  • To evaluate the cytotoxic potential of designed binase-derived peptides against human cancer cell lines.

Main Methods:

  • Synthesis and design of five distinct binase-derived peptides.
  • Assessment of peptide cytotoxicity against human cervical (HeLa), breast (BT-20, MCF-7), and lung adenocarcinoma (A549) cancer cells.
  • Analysis of peptide cellular uptake mechanisms and receptor interactions.

Main Results:

  • Peptides corresponding to binase regions 21-50 (B21-50) and 74-94 (B74-94) exhibited the highest cytotoxicity against HeLa, BT-20, and MCF-7 cells.
  • B21-50 and B74-94 peptides were unable to penetrate A549 cells, correlating with their lack of proliferation inhibition in this cell line.
  • Peptide B74-94 showed structural similarity to epidermal growth factor (EGF), suggesting potential targeting of the EGF receptor overexpressed in BT-20 cells.

Conclusions:

  • Binase-derived peptides, particularly B21-50 and B74-94, possess significant cytotoxic potential against specific human cancer types.
  • Differential cellular uptake and potential receptor-specific interactions influence the efficacy of these peptides.
  • These binase fragments represent promising candidates for further development into novel tumor-targeting therapeutic agents.

Related Concept Videos

Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
13.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.9K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.3K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.2K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
71.0K